Peak6 Investments LLC Ptc Therapeutics, Inc. Transaction History

Peak6 Investments LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 12, 2021	SELL	$47.96 - $67.64 $21,438 - $30,235	-447 Closed	0 $0
Q3 2020 Nov 13, 2020	SELL	$45.41 - $57.07 $16,120 - $20,259	-355 Reduced 44.26%	447 $20,000
Q2 2020 Aug 14, 2020	SELL	$42.56 - $54.98 $85,077 - $109,905	-1,999 Reduced 71.37%	802 $41,000
Q1 2020 May 14, 2020	BUY	$32.37 - $59.36 $51,759 - $94,916	1,599 Added 133.03%	2,801 $125,000
Q4 2019 Feb 13, 2020	SELL	$32.22 - $50.07 $178,112 - $276,786	-5,528 Reduced 82.14%	1,202 $58,000
Q3 2019 Nov 08, 2019	BUY	$33.82 - $48.17 $39,062 - $55,636	1,155 Added 20.72%	6,730 $228,000
Q2 2019 Aug 14, 2019	SELL	$35.42 - $45.0 $122,836 - $156,060	-3,468 Reduced 38.35%	5,575 $251,000
Q1 2019 May 15, 2019	SELL	$28.09 - $39.49 $253,062 - $355,765	-9,009 Reduced 49.91%	9,043 $340,000
Q4 2018 Feb 13, 2019	BUY	$29.83 - $46.51 $322,193 - $502,354	10,801 Added 148.96%	18,052 $620,000
Q3 2018 Nov 13, 2018	BUY	$33.9 - $47.77 $245,808 - $346,380	7,251 New	7,251 $341,000

221

78.1M

144K

58.7K

Ticker PTCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,541,000
Market Cap $3.28B
Description
PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...

Get notified when there are updates to the investment portfolio of Peak6 Investments LLC, based on Form 13F filings with the SEC.

Stay updated on Peak6 Investments LLC with notifications on news.